Recalls
Searchable archive of product recalls from the FDA, USDA FSIS, CPSC, NHTSA, and EPA — translated into plain English, severity-scored from objective criteria, and always linked back to the original government notice.
Every recall on this list has been scored 1–5 against an objective rubric from the agency’s own classification, presence of reported injuries or deaths, distribution scope, and hazard type. The colored severity badge on each card is the score — 5 (Critical) means deaths or serious injuries are reported, 4 (Severe) means significant injury or hospitalization risk, and 3 (High) means a known hazard with no confirmed harm yet. Filter to 3+ (High and above) if you want to skip routine Class-III notices.
The agency chips above control which streams are visible. FDA spans food, drugs, and medical devices. USDA FSIS is meat, poultry, and processed egg products. CPSC is household consumer products. NHTSA is vehicles, tires, and child seats. Nationwide on a card means the recall affects every US state — most do — while a state list means distribution was limited.
Click any recall to see the full summary, affected lot codes and model numbers, the agency’s own classification, and a direct link back to the original government notice for verification.
Minimum severity
Professional Compounding Pharmacy is recalling Acetyl-L-Cysteine 10% eye drops because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.
Health Solutions Pharmacy Center is recalling compounded papaverine-phenolamine-PGE1 injectable vials because FDA inspectors observed insanitary conditions during the compounding process.
The FDA is recalling compounded Papaverine-Phentolamine-PGE1 injectable products from Professional Compounding Pharmacy in Oregon due to insanitary conditions observed during compounding.
Professional Compounding Pharmacy is recalling a compounded sterile injectable drug due to insanitary conditions observed during an FDA inspection.
Professional Compounding Pharmacy is recalling Papaverine-Phentolamine-PGE1 injectable due to insanitary conditions observed during compounding.
Professional Compounding Pharmacy is recalling a specific lot of Papaverine-Phentolamine-PGE1 injectable because FDA inspectors found insanitary conditions during the compounding of sterile drugs.
RemedyRepack Inc. is recalling Losartan 50mg tablets because trace amounts of an unexpected impurity, NMBA, were detected in the active ingredient.
Professional Compounding Pharmacy is recalling compounded papaverine-phentolamine-PGE1 injectable due to insanitary conditions observed during an FDA inspection.
Professional Compounding Pharmacy is recalling a compounded sterile injectable drug due to insanitary conditions observed during an FDA inspection.
Torrent Pharma Inc. is recalling Losartan Potassium / Hydrochlorothiazide Tablets because FDA testing found an impurity above acceptable levels.
Pharma Pac is recalling Losartan Potassium 100 mg tablets because traces of a nitrosamine impurity were found in the active ingredient.
Health Solutions Pharmacy Center Inc is recalling Papaverine-Phentolamine 30-0.5 mg/ml injectable due to insanitary conditions observed during compounding.
FDA is recalling specific lots of Papaverine-Phentolamine-PGE1 Injectable due to insanitary conditions observed during compounding.
Professional Compounding Pharmacy is recalling compounded papaverine-phenolamine-PGE1 injections due to insanitary conditions observed during an FDA inspection.
Torrent Pharma Inc. is recalling Losartan Potassium Tablets, 25 mg, because FDA labs found an impurity above acceptable levels.
Health Solutions Pharmacy Center is recalling compounded Papaverine-Phentolamine-PGE1 injectables because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.
Professional Compounding Pharmacy is recalling 12 prescriptions of Dexamethasone eye drops due to insanitary conditions observed during compounding.
FDA is recalling compounded Papaverine-Phentolamine-PGE1 injectable vials from Professional Compounding Pharmacy due to insanitary conditions observed during compounding.
Professional Compounding Pharmacy is recalling Hydroxyprogesterone Caproate 250 mg/mL injectable because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.
Glenmark Pharmaceuticals is recalling 2,076 bottles of Pravastatin Sodium 20 mg tablets because a foreign tablet was found in the product.
McDaniel Life-Line LLC is voluntarily recalling Life-Line Catalytic Activated Energy Water because it is an unapproved new drug. The product was distributed in the US and several international countries.
Professional Compounding Pharmacy is recalling PGE1-Lidocaine injectable products because FDA inspectors observed insanitary conditions during the compounding of sterile drugs.
Pfizer is recalling 8.4% Sodium Bicarbonate Injection vials because they contain glass particulates. The recall covers 283,400 vials distributed in the United States and Puerto Rico.
Legacy Pharmaceutical Packaging LLC is recalling Losartan Potassium Tablets, 50 mg, because an impurity was detected. The recall covers 179,544 bottles distributed in Arizona, Indiana, and Tennessee.
Johnson Matthey Inc. is recalling Morphine Sulfate USP Milled API due to bioburden out of specification results.